申请人:IRONWOOD PHARMACEUTICALS INC
公开号:WO2014047111A1
公开(公告)日:2014-03-27
Compounds of Formula I are described. They are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds may be useful for treating, preventing or managing various disorders that are herein disclosed.
描述了式I的化合物。它们可作为sGC的刺激剂,特别是独立于NO的、依赖血红素的刺激剂。这些化合物可能对治疗、预防或管理本文中披露的各种疾病有用。